-
1
-
-
84934936350
-
Environmental risk factors in inflammatory bowel disease: A population-based case-control study in Asia-Pacific
-
Asia-Pacific Crohn's and Colitis Epidemiology Study ACCESS Group
-
Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling KL, Ong D, Goh KL, Hilmi I, Ouyang Q, Wang YF, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B, Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M, Abdullah M, Tsang SW, Wong TC, Hui AJ, Chow CM, Yu HH, Li MF, Ng KK, Ching J, Wu JC, Chan FK, Sung JJ; Asia-Pacific Crohn's and Colitis Epidemiology Study ACCESS Group. 2015. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 64:1063-1071. https://doi.org/10.1136/gutjnl-2014-307410.
-
(2015)
Gut
, vol.64
, pp. 1063-1071
-
-
Ng, S.C.1
Tang, W.2
Leong, R.W.3
Chen, M.4
Ko, Y.5
Studd, C.6
Niewiadomski, O.7
Bell, S.8
Kamm, M.A.9
De Silva, H.J.10
Kasturiratne, A.11
Senanayake, Y.U.12
Ooi, C.J.13
Ling, K.L.14
Ong, D.15
Goh, K.L.16
Hilmi, I.17
Ouyang, Q.18
Wang, Y.F.19
Hu, P.20
Zhu, Z.21
Zeng, Z.22
Wu, K.23
Wang, X.24
Xia, B.25
Li, J.26
Pisespongsa, P.27
Manatsathit, S.28
Aniwan, S.29
Simadibrata, M.30
Abdullah, M.31
Tsang, S.W.32
Wong, T.C.33
Hui, A.J.34
Chow, C.M.35
Yu, H.H.36
Li, M.F.37
Ng, K.K.38
Ching, J.39
Wu, J.C.40
Chan, F.K.41
Sung, J.J.42
more..
-
2
-
-
84868336049
-
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
-
Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124. https://doi.org/10.1038/nature11582.
-
(2012)
Nature
, vol.491
, pp. 119-124
-
-
Jostins, L.1
Ripke, S.2
Weersma, R.K.3
Duerr, R.H.4
McGovern, D.P.5
Hui, K.Y.6
Lee, J.C.7
Schumm, L.P.8
Sharma, Y.9
Anderson, C.A.10
Essers, J.11
Mitrovic, M.12
Ning, K.13
Cleynen, I.14
Theatre, E.15
Spain, S.L.16
Raychaudhuri, S.17
Goyette, P.18
Wei, Z.19
Abraham, C.20
Achkar, J.P.21
Ahmad, T.22
Amininejad, L.23
Ananthakrishnan, A.N.24
Andersen, V.25
Andrews, J.M.26
Baidoo, L.27
Balschun, T.28
Bampton, P.A.29
Bitton, A.30
Boucher, G.31
Brand, S.32
Buning, C.33
Cohain, A.34
Cichon, S.35
D'Amato, M.36
De Jong, D.37
Devaney, K.L.38
Dubinsky, M.39
Edwards, C.40
Ellinghaus, D.41
Ferguson, L.R.42
Franchimont, D.43
Fransen, K.44
Gearry, R.45
Georges, M.46
Gieger, C.47
Glas, J.48
Haritunians, T.49
Hart, A.50
more..
-
4
-
-
0035978651
-
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
-
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603. https://doi.org/ 10.1038/35079107.
-
(2001)
Nature
, vol.411
, pp. 599-603
-
-
Hugot, J.P.1
Chamaillard, M.2
Zouali, H.3
Lesage, S.4
Cézard, J.P.5
Belaiche, J.6
Almer, S.7
Tysk, C.8
O'Morain, C.A.9
Gassull, M.10
Binder, V.11
Finkel, Y.12
Cortot, A.13
Modigliani, R.14
Laurent-Puig, P.15
Gower-Rousseau, C.16
Macry, J.17
Colombel, J.F.18
Sahbatou, M.19
Thomas, G.20
more..
-
5
-
-
0035978533
-
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
-
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606. https://doi.org/10.1038/35079114.
-
(2001)
Nature
, vol.411
, pp. 603-606
-
-
Ogura, Y.1
Bonen, D.K.2
Inohara, N.3
Nicolae, D.L.4
Chen, F.F.5
Ramos, R.6
Britton, H.7
Moran, T.8
Karaliuskas, R.9
Duerr, R.H.10
Achkar, J.P.11
Brant, S.R.12
Bayless, T.M.13
Kirschner, B.S.14
Hanauer, S.B.15
Nuñez, G.16
Cho, J.H.17
-
6
-
-
30944466824
-
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
-
Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:205-211. https://doi.org/10.1136/gut.2005 .073817.
-
(2006)
Gut
, vol.55
, pp. 205-211
-
-
Manichanh, C.1
Rigottier-Gois, L.2
Bonnaud, E.3
Gloux, K.4
Pelletier, E.5
Frangeul, L.6
Nalin, R.7
Jarrin, C.8
Chardon, P.9
Marteau, P.10
Roca, J.11
Dore, J.12
-
7
-
-
84863105536
-
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease
-
Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ. 2012. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One 7:e39242. https://doi.org/10.1371/journal.pone.0039242.
-
(2012)
PLoS One
, vol.7
, pp. e39242
-
-
Papa, E.1
Docktor, M.2
Smillie, C.3
Weber, S.4
Preheim, S.P.5
Gevers, D.6
Giannoukos, G.7
Ciulla, D.8
Tabbaa, D.9
Ingram, J.10
Schauer, D.B.11
Ward, D.V.12
Korzenik, J.R.13
Xavier, R.J.14
Bousvaros, A.15
Alm, E.J.16
-
8
-
-
84900399621
-
IBD. Understanding gut microbiota in new-onset Crohn's disease
-
Ray K. 2014. IBD. Understanding gut microbiota in new-onset Crohn's disease. Nat Rev Gastroenterol Hepatol 11:268. https://doi.org/10.1038/ nrgastro.2014.45.
-
(2014)
Nat Rev Gastroenterol Hepatol
, vol.11
, pp. 268
-
-
Ray, K.1
-
9
-
-
84896092821
-
The treatment-naive microbiome in new-onset Crohn's disease
-
Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, González A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ. 2014. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15:382-392. https://doi.org/10.1016/j.chom.2014.02 .005.
-
(2014)
Cell Host Microbe
, vol.15
, pp. 382-392
-
-
Gevers, D.1
Kugathasan, S.2
Denson, L.A.3
Vázquez-Baeza, Y.4
Van Treuren, W.5
Ren, B.6
Schwager, E.7
Knights, D.8
Song, S.J.9
Yassour, M.10
Morgan, X.C.11
Kostic, A.D.12
Luo, C.13
González, A.14
McDonald, D.15
Haberman, Y.16
Walters, T.17
Baker, S.18
Rosh, J.19
Stephens, M.20
Heyman, M.21
Markowitz, J.22
Baldassano, R.23
Griffiths, A.24
Sylvester, F.25
Mack, D.26
Kim, S.27
Crandall, W.28
Hyams, J.29
Huttenhower, C.30
Knight, R.31
Xavier, R.J.32
more..
-
10
-
-
78650099360
-
Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases
-
Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N, Pace NR, Li E. 2011. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 17:179-184. https://doi.org/10.1002/ibd.21339.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 179-184
-
-
Frank, D.N.1
Robertson, C.E.2
Hamm, C.M.3
Kpadeh, Z.4
Zhang, T.5
Chen, H.6
Zhu, W.7
Sartor, R.B.8
Boedeker, E.C.9
Harpaz, N.10
Pace, N.R.11
Li, E.12
-
11
-
-
84866549438
-
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
-
Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13:R79. https://doi.org/10.1186/gb-2012-13-9-r79.
-
(2012)
Genome Biol
, vol.13
, pp. R79
-
-
Morgan, X.C.1
Tickle, T.L.2
Sokol, H.3
Gevers, D.4
Devaney, K.L.5
Ward, D.V.6
Reyes, J.A.7
Shah, S.A.8
LeLeiko, N.9
Snapper, S.B.10
Bousvaros, A.11
Korzenik, J.12
Sands, B.E.13
Xavier, R.J.14
Huttenhower, C.15
-
12
-
-
79959835543
-
Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis
-
Andoh A, Imaeda H, Aomatsu T, Inatomi O, Bamba S, Sasaki M, Saito Y, Tsujikawa T, Fujiyama Y. 2011. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 46: 479-486. https://doi.org/10.1007/s00535-010-0368-4.
-
(2011)
J Gastroenterol
, vol.46
, pp. 479-486
-
-
Andoh, A.1
Imaeda, H.2
Aomatsu, T.3
Inatomi, O.4
Bamba, S.5
Sasaki, M.6
Saito, Y.7
Tsujikawa, T.8
Fujiyama, Y.9
-
13
-
-
84875717908
-
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease
-
Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, Matsui T, Fujiyama Y, Matsumoto T. 2012. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol 47:1298-1307. https://doi.org/10.1007/s00535-012-0605-0.
-
(2012)
J Gastroenterol
, vol.47
, pp. 1298-1307
-
-
Andoh, A.1
Kuzuoka, H.2
Tsujikawa, T.3
Nakamura, S.4
Hirai, F.5
Suzuki, Y.6
Matsui, T.7
Fujiyama, Y.8
Matsumoto, T.9
-
14
-
-
84938704882
-
Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid
-
Kabeerdoss J, Jayakanthan P, Pugazhendhi S, Ramakrishna BS. 2015. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Indian J Med Res 142: 23-32. https://doi.org/10.4103/0971-5916.162091.
-
(2015)
Indian J Med Res
, vol.142
, pp. 23-32
-
-
Kabeerdoss, J.1
Jayakanthan, P.2
Pugazhendhi, S.3
Ramakrishna, B.S.4
-
15
-
-
84876501381
-
The dynamics of gut-associated microbial communities during inflammation
-
Winter SE, Lopez CA, Bäumler AJ. 2013. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep 14:319-327. https://doi.org/10.1038/embor.2013.27.
-
(2013)
EMBO Rep
, vol.14
, pp. 319-327
-
-
Winter, S.E.1
Lopez, C.A.2
Bäumler, A.J.3
-
16
-
-
84879479335
-
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and Colitis Epidemiology Study
-
Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group
-
Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MN, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJ, Chan FK, Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. 2013. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and Colitis Epidemiology Study. Gastroenterology 145:158-165.e2. https://doi.org/10.1053/j.gastro.2013 .04.007.
-
(2013)
Gastroenterology
, vol.145
, pp. 158e2-165e2
-
-
Ng, S.C.1
Tang, W.2
Ching, J.Y.3
Wong, M.4
Chow, C.M.5
Hui, A.J.6
Wong, T.C.7
Leung, V.K.8
Tsang, S.W.9
Yu, H.H.10
Li, M.F.11
Ng, K.K.12
Kamm, M.A.13
Studd, C.14
Bell, S.15
Leong, R.16
De Silva, H.J.17
Kasturiratne, A.18
Mufeena, M.N.19
Ling, K.L.20
Ooi, C.J.21
Tan, P.S.22
Ong, D.23
Goh, K.L.24
Hilmi, I.25
Pisespongsa, P.26
Manatsathit, S.27
Rerknimitr, R.28
Aniwan, S.29
Wang, Y.F.30
Ouyang, Q.31
Zeng, Z.32
Zhu, Z.33
Chen, M.H.34
Hu, P.J.35
Wu, K.36
Wang, X.37
Simadibrata, M.38
Abdullah, M.39
Wu, J.C.40
Sung, J.J.41
Chan, F.K.42
more..
-
17
-
-
84862141704
-
Human gut microbiome viewed across age and geography
-
Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI. 2012. Human gut microbiome viewed across age and geography. Nature 486:222-227. https:// doi.org/10.1038/nature11053.
-
(2012)
Nature
, vol.486
, pp. 222-227
-
-
Yatsunenko, T.1
Rey, F.E.2
Manary, M.J.3
Trehan, I.4
Dominguez-Bello, M.G.5
Contreras, M.6
Magris, M.7
Hidalgo, G.8
Baldassano, R.N.9
Anokhin, A.P.10
Heath, A.C.11
Warner, B.12
Reeder, J.13
Kuczynski, J.14
Caporaso, J.G.15
Lozupone, C.A.16
Lauber, C.17
Clemente, J.C.18
Knights, D.19
Knight, R.20
Gordon, J.I.21
more..
-
18
-
-
79955561083
-
Epidemiology and natural history of inflammatory bowel diseases
-
Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. 2011. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140: 1785-1794. https://doi.org/10.1053/j.gastro.2011.01.055.
-
(2011)
Gastroenterology
, vol.140
, pp. 1785-1794
-
-
Cosnes, J.1
Gower-Rousseau, C.2
Seksik, P.3
Cortot, A.4
-
19
-
-
0029050742
-
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
-
van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J. 1995. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129-135. https://doi.org/10.1016/0016-5085(95)90277-5.
-
(1995)
Gastroenterology
, vol.109
, pp. 129-135
-
-
Van Dullemen, H.M.1
Van Deventer, S.J.2
Hommes, D.W.3
Bijl, H.A.4
Jansen, J.5
Tytgat, G.N.6
Woody, J.7
-
20
-
-
84942775653
-
Infliximab for the treatment of Crohn's disease
-
Zhou Y, He H, Wang P, Zhang T, Lin M, Wang H, Nie Y, Chen Y. 2015. Infliximab for the treatment of Crohn's disease. Eur J Gastroenterol Hepatol 27:1270-1275. https://doi.org/10.1097/MEG.0000000000000447.
-
(2015)
Eur J Gastroenterol Hepatol
, vol.27
, pp. 1270-1275
-
-
Zhou, Y.1
He, H.2
Wang, P.3
Zhang, T.4
Lin, M.5
Wang, H.6
Nie, Y.7
Chen, Y.8
-
21
-
-
84906817410
-
Efficacy and safety of infliximab in treating patients with ulcerative colitis: Experiences from a single medical center in southern China
-
Zhou YL, Xie S, Wang P, Zhang T, Lin MY, Tan JS, Zhi FC, Jiang B, Chen Y. 2014. Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China. J Dig Dis 15:483-490. https://doi.org/10.1111/1751-2980.12161.
-
(2014)
J Dig Dis
, vol.15
, pp. 483-490
-
-
Zhou, Y.L.1
Xie, S.2
Wang, P.3
Zhang, T.4
Lin, M.Y.5
Tan, J.S.6
Zhi, F.C.7
Jiang, B.8
Chen, Y.9
-
22
-
-
33644859927
-
Predictors of Crohn's disease
-
Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. 2006. Predictors of Crohn's disease. Gastroenterology 130:650-656. https:// doi.org/10.1053/j.gastro.2005.12.019.
-
(2006)
Gastroenterology
, vol.130
, pp. 650-656
-
-
Beaugerie, L.1
Seksik, P.2
Nion-Larmurier, I.3
Gendre, J.P.4
Cosnes, J.5
-
23
-
-
14544308315
-
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
-
Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M. 2005. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 54:364-368. https://doi.org/10.1136/gut.2004.043406.
-
(2005)
Gut
, vol.54
, pp. 364-368
-
-
Costa, F.1
Mumolo, M.G.2
Ceccarelli, L.3
Bellini, M.4
Romano, M.R.5
Sterpi, C.6
Ricchiuti, A.7
Marchi, S.8
Bottai, M.9
-
24
-
-
79955555545
-
The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease
-
Lewis JD. 2011. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 140:1817-1826.e2. https://doi.org/10.1053/j.gastro.2010.11.058.
-
(2011)
Gastroenterology
, vol.140
, pp. 1817e2-1826e2
-
-
Lewis, J.D.1
-
25
-
-
0030897788
-
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein
-
Røseth AG, Aadland E, Jahnsen J, Raknerud N. 1997. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 58:176-180. https://doi.org/10.1159/ 000201441.
-
(1997)
Digestion
, vol.58
, pp. 176-180
-
-
Røseth, A.G.1
Aadland, E.2
Jahnsen, J.3
Raknerud, N.4
-
26
-
-
84861869143
-
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
-
Mao R, Xiao YL, Gao X, Chen BL, He Y, Yang L, Hu PJ, Chen MH. 2012. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies. Inflamm Bowel Dis 18: 1894-1899. https://doi.org/10.1002/ibd.22861.
-
(2012)
Inflamm Bowel Dis
, vol.18
, pp. 1894-1899
-
-
Mao, R.1
Xiao, Y.L.2
Gao, X.3
Chen, B.L.4
He, Y.5
Yang, L.6
Hu, P.J.7
Chen, M.H.8
-
27
-
-
79751472562
-
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop, which drug to choose, and how to predict response?
-
quiz 213
-
D'Haens GR, Panaccione R, Higgins PD, Vermeire S, Gassull M, Chowers Y, Hanauer SB, Herfarth H, Hommes DW, Kamm M, Lofberg R, Quary A, Sands B, Sood A, Watermeyer G, Lashner B, Lemann M, Plevy S, Reinisch W, Schreiber S, Siegel C, Targan S, Watanabe M, Feagan B, Sandborn WJ, Colombel JF, Travis S. 2011. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol 106:199-212; quiz 213.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 199-212
-
-
D'Haens, G.R.1
Panaccione, R.2
Higgins, P.D.3
Vermeire, S.4
Gassull, M.5
Chowers, Y.6
Hanauer, S.B.7
Herfarth, H.8
Hommes, D.W.9
Kamm, M.10
Lofberg, R.11
Quary, A.12
Sands, B.13
Sood, A.14
Watermeyer, G.15
Lashner, B.16
Lemann, M.17
Plevy, S.18
Reinisch, W.19
Schreiber, S.20
Siegel, C.21
Targan, S.22
Watanabe, M.23
Feagan, B.24
Sandborn, W.J.25
Colombel, J.F.26
Travis, S.27
more..
-
28
-
-
84902150181
-
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease
-
Rajca S, Grondin V, Louis E, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Paintaud G, Piver E, Allez M, Mary JY, Sokol H, Colombel JF, Seksik P. 2014. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis 20:978-986. https://doi.org/10.1097/ MIB.0000000000000036.
-
(2014)
Inflamm Bowel Dis
, vol.20
, pp. 978-986
-
-
Rajca, S.1
Grondin, V.2
Louis, E.3
Vernier-Massouille, G.4
Grimaud, J.C.5
Bouhnik, Y.6
Laharie, D.7
Dupas, J.L.8
Pillant, H.9
Picon, L.10
Veyrac, M.11
Flamant, M.12
Savoye, G.13
Jian, R.14
Devos, M.15
Paintaud, G.16
Piver, E.17
Allez, M.18
Mary, J.Y.19
Sokol, H.20
Colombel, J.F.21
Seksik, P.22
more..
-
29
-
-
84930760898
-
Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation
-
Kolho KL, Korpela K, Jaakkola T, Pichai MV, Zoetendal EG, Salonen A, de Vos WM. 2015. Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am J Gastroenterol 110:921-930. https:// doi.org/10.1038/ajg.2015.149.
-
(2015)
Am J Gastroenterol
, vol.110
, pp. 921-930
-
-
Kolho, K.L.1
Korpela, K.2
Jaakkola, T.3
Pichai, M.V.4
Zoetendal, E.G.5
Salonen, A.6
De Vos, W.M.7
-
30
-
-
84906077087
-
Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease
-
Chen L, Wang W, Zhou R, Ng SC, Li J, Huang M, Zhou F, Wang X, Shen B, A Kamm M, Wu K, Xia B. 2014. Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Medicine 93:e51. https://doi.org/10.1097/MD.0000000000000051.
-
(2014)
Medicine
, vol.93
, pp. e51
-
-
Chen, L.1
Wang, W.2
Zhou, R.3
Ng, S.C.4
Li, J.5
Huang, M.6
Zhou, F.7
Wang, X.8
Shen, B.9
Kamm, M.A.10
Wu, K.11
Xia, B.12
-
31
-
-
84873717548
-
The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease
-
Sha S, Xu B, Wang X, Zhang Y, Wang H, Kong X, Zhu H, Wu K. 2013. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagn Microbiol Infect Dis 75:245-251. https://doi.org/10.1016/j.diagmicrobio.2012.11.022.
-
(2013)
Diagn Microbiol Infect Dis
, vol.75
, pp. 245-251
-
-
Sha, S.1
Xu, B.2
Wang, X.3
Zhang, Y.4
Wang, H.5
Kong, X.6
Zhu, H.7
Wu, K.8
-
32
-
-
2342442430
-
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
-
Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. 2004. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53:685-693. https://doi.org/10.1136/gut.2003.025403.
-
(2004)
Gut
, vol.53
, pp. 685-693
-
-
Ott, S.J.1
Musfeldt, M.2
Wenderoth, D.F.3
Hampe, J.4
Brant, O.5
Fölsch, U.R.6
Timmis, K.N.7
Schreiber, S.8
-
33
-
-
84908348194
-
Meta-analyses of human gut microbes associated with obesity and IBD
-
Walters WA, Xu Z, Knight R. 2014. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 588:4223-4233. https://doi .org/10.1016/j.febslet.2014.09.039.
-
(2014)
FEBS Lett
, vol.588
, pp. 4223-4233
-
-
Walters, W.A.1
Xu, Z.2
Knight, R.3
-
34
-
-
29144464937
-
UniFrac: A new phylogenetic method for comparing microbial communities
-
Lozupone C, Knight R. 2005. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71: 8228-8235. https://doi.org/10.1128/AEM.71.12.8228-8235.2005.
-
(2005)
Appl Environ Microbiol
, vol.71
, pp. 8228-8235
-
-
Lozupone, C.1
Knight, R.2
-
35
-
-
84893776494
-
Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease
-
Prideaux L, Kang S, Wagner J, Buckley M, Mahar JE, De Cruz P, Wen Z, Chen L, Xia B, van Langenberg DR, Lockett T, Ng SC, Sung JJ, Desmond P, McSweeney C, Morrison M, Kirkwood CD, Kamm MA. 2013. Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis 19:2906-2918. https:// doi.org/10.1097/01.MIB.0000435759.05577.12.
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 2906-2918
-
-
Prideaux, L.1
Kang, S.2
Wagner, J.3
Buckley, M.4
Mahar, J.E.5
De Cruz, P.6
Wen, Z.7
Chen, L.8
Xia, B.9
Van Langenberg, D.R.10
Lockett, T.11
Ng, S.C.12
Sung, J.J.13
Desmond, P.14
McSweeney, C.15
Morrison, M.16
Kirkwood, C.D.17
Kamm, M.A.18
-
36
-
-
85019590191
-
The socio-economic impact of work disability due to inflammatory bowel disease in Brazil
-
Fróes RDSB, Pugas Carvalho AT, Carneiro AJDV, de Barros Moreira AMH, Moreira JPL, Luiz RR, de Souza HS. 2017. The socio-economic impact of work disability due to inflammatory bowel disease in Brazil. Eur J Health Econ. https://doi.org/10.1007/s10198-017-0896-4.
-
(2017)
Eur J Health Econ
-
-
Fróes, R.D.S.B.1
Pugas Carvalho, A.T.2
Carneiro, A.J.D.V.3
De Barros Moreira, A.M.H.4
Moreira, J.P.L.5
Luiz, R.R.6
De Souza, H.S.7
-
37
-
-
85006975281
-
Epidemiology: Rising in the east
-
Chi KR. 2016. Epidemiology: rising in the east. Nature 540:S100-SS102. https://doi.org/10.1038/540S100a.
-
(2016)
Nature
, vol.540
, pp. S100-SS102
-
-
Chi, K.R.1
-
38
-
-
84940771118
-
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
-
International Multiple Sclerosis Genetics Consortium; International IBD Genetics Consortium, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK
-
Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK; International Multiple Sclerosis Genetics Consortium; International IBD Genetics Consortium, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK. 2015. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47:979-986.
-
(2015)
Nat Genet
, vol.47
, pp. 979-986
-
-
Liu, J.Z.1
Van Sommeren, S.2
Huang, H.3
Ng, S.C.4
Alberts, R.5
Takahashi, A.6
Ripke, S.7
Lee, J.C.8
Jostins, L.9
Shah, T.10
Abedian, S.11
Cheon, J.H.12
Cho, J.13
Dayani, N.E.14
Franke, L.15
Fuyuno, Y.16
Hart, A.17
Juyal, R.C.18
Juyal, G.19
Kim, W.H.20
Morris, A.P.21
Poustchi, H.22
Newman, W.G.23
Midha, V.24
Orchard, T.R.25
Vahedi, H.26
Sood, A.27
Sung, J.Y.28
Malekzadeh, R.29
Westra, H.J.30
Yamazaki, K.31
Yang, S.K.32
more..
-
39
-
-
84966293351
-
Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
-
Chu H, Khosravi A, Kusumawardhani IP, Kwon AH, Vasconcelos AC, Cunha LD, Mayer AE, Shen Y, Wu WL, Kambal A, Targan SR, Xavier RJ, Ernst PB, Green DR, McGovern DP, Virgin HW, Mazmanian SK. 2016. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 352:1116-1120. https://doi.org/10.1126/ science.aad9948.
-
(2016)
Science
, vol.352
, pp. 1116-1120
-
-
Chu, H.1
Khosravi, A.2
Kusumawardhani, I.P.3
Kwon, A.H.4
Vasconcelos, A.C.5
Cunha, L.D.6
Mayer, A.E.7
Shen, Y.8
Wu, W.L.9
Kambal, A.10
Targan, S.R.11
Xavier, R.J.12
Ernst, P.B.13
Green, D.R.14
McGovern, D.P.15
Virgin, H.W.16
Mazmanian, S.K.17
-
40
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: The ACCENT i randomised trial
-
ACCENT I Study Group
-
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. 2002. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359:1541-1549. https:// doi.org/10.1016/S0140-6736(02)08512-4.
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
41
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. 2005. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462-2476. https://doi.org/10.1056/NEJMoa050516.
-
(2005)
N Engl J Med
, vol.353
, pp. 2462-2476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
Reinisch, W.4
Olson, A.5
Johanns, J.6
Travers, S.7
Rachmilewitz, D.8
Hanauer, S.B.9
Lichtenstein, G.R.10
De Villiers, W.J.11
Present, D.12
Sands, B.E.13
Colombel, J.F.14
-
42
-
-
84963860997
-
Helminth infection promotes colonization resistance via type 2 immunity
-
Ramanan D, Bowcutt R, Lee SC, Tang MS, Kurtz ZD, Ding Y, Honda K, Gause WC, Blaser MJ, Bonneau RA, Lim YA, Loke P, Cadwell K. 2016. Helminth infection promotes colonization resistance via type 2 immunity. Science 352:608-612. https://doi.org/10.1126/science.aaf3229.
-
(2016)
Science
, vol.352
, pp. 608-612
-
-
Ramanan, D.1
Bowcutt, R.2
Lee, S.C.3
Tang, M.S.4
Kurtz, Z.D.5
Ding, Y.6
Honda, K.7
Gause, W.C.8
Blaser, M.J.9
Bonneau, R.A.10
Lim, Y.A.11
Loke, P.12
Cadwell, K.13
-
43
-
-
84876841275
-
Butyrateproducing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model
-
Van den Abbeele P, Belzer C, Goossens M, Kleerebezem M, De Vos WM, Thas O, De Weirdt R, Kerckhof FM, Van de Wiele T. 2013. Butyrateproducing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J 7:949-961. https://doi.org/10.1038/ismej .2012.158.
-
(2013)
ISME J
, vol.7
, pp. 949-961
-
-
Van Den Abbeele, P.1
Belzer, C.2
Goossens, M.3
Kleerebezem, M.4
De Vos, W.M.5
Thas, O.6
De Weirdt, R.7
Kerckhof, F.M.8
Van De Wiele, T.9
-
44
-
-
85027947787
-
Induction of colonic regulatory T cells by indigenous Clostridium species
-
Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-341. https://doi.org/ 10.1126/science.1198469.
-
(2011)
Science
, vol.331
, pp. 337-341
-
-
Atarashi, K.1
Tanoue, T.2
Shima, T.3
Imaoka, A.4
Kuwahara, T.5
Momose, Y.6
Cheng, G.7
Yamasaki, S.8
Saito, T.9
Ohba, Y.10
Taniguchi, T.11
Takeda, K.12
Hori, S.13
Ivanov, I.I.14
Umesaki, Y.15
Itoh, K.16
Honda, K.17
-
45
-
-
0025141803
-
The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system
-
Vince AJ, McNeil NI, Wager JD, Wrong OM. 1990. The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system. Br J Nutr 63:17-26. https://doi.org/10.1079/BJN19900088.
-
(1990)
Br J Nutr
, vol.63
, pp. 17-26
-
-
Vince, A.J.1
McNeil, N.I.2
Wager, J.D.3
Wrong, O.M.4
-
46
-
-
55949124035
-
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
-
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736. https://doi.org/10.1073/pnas.0804812105.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 16731-16736
-
-
Sokol, H.1
Pigneur, B.2
Watterlot, L.3
Lakhdari, O.4
Bermúdez-Humarán, L.G.5
Gratadoux, J.J.6
Blugeon, S.7
Bridonneau, C.8
Furet, J.P.9
Corthier, G.10
Grangette, C.11
Vasquez, N.12
Pochart, P.13
Trugnan, G.14
Thomas, G.15
Blottière, H.M.16
Doré, J.17
Marteau, P.18
Seksik, P.19
Langella, P.20
more..
-
47
-
-
0024810567
-
Classification of inflammatory bowel disease
-
discussion 16-19
-
Lennard-Jones JE. 1989. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6; discussion 16-19. https://doi.org/ 10.3109/00365528909091339.
-
(1989)
Scand J Gastroenterol Suppl
, vol.170
, pp. 2-6
-
-
Lennard-Jones, J.E.1
-
48
-
-
33646778482
-
The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications
-
Satsangi J, Silverberg MS, Vermeire S, Colombel JF. 2006. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749-753. https://doi.org/10.1136/gut.2005 .082909.
-
(2006)
Gut
, vol.55
, pp. 749-753
-
-
Satsangi, J.1
Silverberg, M.S.2
Vermeire, S.3
Colombel, J.F.4
-
49
-
-
75149129948
-
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
-
European Crohn's and Colitis Organisation (ECCO)
-
Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E; European Crohn's and Colitis Organisation (ECCO). 2010. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 4:7-27. https://doi.org/10.1016/j.crohns.2009.12.003.
-
(2010)
J Crohns Colitis
, vol.4
, pp. 7-27
-
-
Van Assche, G.1
Dignass, A.2
Panes, J.3
Beaugerie, L.4
Karagiannis, J.5
Allez, M.6
Ochsenkühn, T.7
Orchard, T.8
Rogler, G.9
Louis, E.10
Kupcinskas, L.11
Mantzaris, G.12
Travis, S.13
Stange, E.14
-
50
-
-
84867758755
-
Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation
-
Lu C, Waugh A, Bailey RJ, Cherry R, Dieleman LA, Gramlich L, Matic K, Millan M, Kroeker KI, Sadowski D, Teshima CW, Todoruk D, Wong C, Wong K, Fedorak RN. 2012. Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation. World J Gastroenterol 18:5058-5064. https://doi.org/10.3748/wjg.v18.i36.5058.
-
(2012)
World J Gastroenterol
, vol.18
, pp. 5058-5064
-
-
Lu, C.1
Waugh, A.2
Bailey, R.J.3
Cherry, R.4
Dieleman, L.A.5
Gramlich, L.6
Matic, K.7
Millan, M.8
Kroeker, K.I.9
Sadowski, D.10
Teshima, C.W.11
Todoruk, D.12
Wong, C.13
Wong, K.14
Fedorak, R.N.15
-
51
-
-
84869097466
-
Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children
-
Chen CC, Huang JL, Chang CJ, Kong MS. 2012. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr 55:541-547. https://doi.org/10.1097/MPG.0b013e318262a718.
-
(2012)
J Pediatr Gastroenterol Nutr
, vol.55
, pp. 541-547
-
-
Chen, C.C.1
Huang, J.L.2
Chang, C.J.3
Kong, M.S.4
-
52
-
-
84889102325
-
Comparison of direct boiling method with commercial kits for extracting fecal microbiome DNA by Illumina sequencing of 16S rRNA tags
-
Peng X, Yu KQ, Deng GH, Jiang YX, Wang Y, Zhang GX, Zhou HW. 2013. Comparison of direct boiling method with commercial kits for extracting fecal microbiome DNA by Illumina sequencing of 16S rRNA tags. J Microbiol Methods 95:455-462. https://doi.org/10.1016/j.mimet.2013.07 .015.
-
(2013)
J Microbiol Methods
, vol.95
, pp. 455-462
-
-
Peng, X.1
Yu, K.Q.2
Deng, G.H.3
Jiang, Y.X.4
Wang, Y.5
Zhang, G.X.6
Zhou, H.W.7
-
53
-
-
77952243141
-
QIIME allows analysis of high-throughput community sequencing data
-
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335-336. https://doi.org/10.1038/nmeth.f.303.
-
(2010)
Nat Methods
, vol.7
, pp. 335-336
-
-
Caporaso, J.G.1
Kuczynski, J.2
Stombaugh, J.3
Bittinger, K.4
Bushman, F.D.5
Costello, E.K.6
Fierer, N.7
Peña, A.G.8
Goodrich, J.K.9
Gordon, J.I.10
Huttley, G.A.11
Kelley, S.T.12
Knights, D.13
Koenig, J.E.14
Ley, R.E.15
Lozupone, C.A.16
McDonald, D.17
Muegge, B.D.18
Pirrung, M.19
Reeder, J.20
Sevinsky, J.R.21
Turnbaugh, P.J.22
Walters, W.A.23
Widmann, J.24
Yatsunenko, T.25
Zaneveld, J.26
Knight, R.27
more..
-
54
-
-
84857122937
-
An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea
-
McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P. 2012. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 6:610-618. https://doi.org/10.1038/ismej .2011.139.
-
(2012)
ISME J
, vol.6
, pp. 610-618
-
-
McDonald, D.1
Price, M.N.2
Goodrich, J.3
Nawrocki, E.P.4
DeSantis, T.Z.5
Probst, A.6
Andersen, G.L.7
Knight, R.8
Hugenholtz, P.9
-
55
-
-
84884127512
-
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
-
Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C. 2013. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31: 814-821. https://doi.org/10.1038/nbt.2676.
-
(2013)
Nat Biotechnol
, vol.31
, pp. 814-821
-
-
Langille, M.G.1
Zaneveld, J.2
Caporaso, J.G.3
McDonald, D.4
Knights, D.5
Reyes, J.A.6
Clemente, J.C.7
Burkepile, D.E.8
Vega Thurber, R.L.9
Knight, R.10
Beiko, R.G.11
Huttenhower, C.12
-
56
-
-
79959383523
-
Metagenomic biomarker discovery and explanation
-
Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. 2011. Metagenomic biomarker discovery and explanation. Genome Biol 12:R60. https://doi.org/10.1186/gb-2011-12-6-r60.
-
(2011)
Genome Biol
, vol.12
, pp. R60
-
-
Segata, N.1
Izard, J.2
Waldron, L.3
Gevers, D.4
Miropolsky, L.5
Garrett, W.S.6
Huttenhower, C.7
-
57
-
-
56249113343
-
Building predictive models in R using the Caret package
-
Kuhn M. 2008. Building predictive models in R using the Caret package. J Stat Softw 28:JSSv028i05. https://doi.org/10.18637/jss.v028.i05.
-
(2008)
J Stat Softw
, vol.28
, pp. JSSv028i05
-
-
Kuhn, M.1
-
58
-
-
33646023117
-
An introduction to ROC analysis
-
Fawcett T. 2006. An introduction to ROC analysis. Pattern Recognit Lett 27:861-874. https://doi.org/10.1016/j.patrec.2005.10.010.
-
(2006)
Pattern Recognit Lett
, vol.27
, pp. 861-874
-
-
Fawcett, T.1
-
59
-
-
0345040873
-
Classification and regression by randomForest
-
Liaw A, Wiener M. 2002. Classification and regression by randomForest. R News 2:18-22.
-
(2002)
R News
, vol.2
, pp. 18-22
-
-
Liaw, A.1
Wiener, M.2
|